Article

Role of Raj Nirvan Bati in Treatment of COVID19 RT-PCR Positive Cases

Authors:
Kumar R at All India Institute of Medical Sciences,Rishikesh,India
Kumar R
  • All India Institute of Medical Sciences,Rishikesh,India
Ramakant Yadav at UP University of Medical Sciences
Ramakant Yadav
  • UP University of Medical Sciences
Ramakant Rawat at Up university of medical sciences saifai Etawah
Ramakant Rawat
  • Up university of medical sciences saifai Etawah
Prashant Kumar Bajpai at King George's Medical University
Prashant Kumar Bajpai
Show all 7 authorsHide
Download citation
To read the full-text of this research, you can request a copy directly from the authors.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the authors.

... 17 Studies have documented that the hemoglobin value is significantly lower in COVID-19 cases with severe disease than those in milder forms. [18][19][20] The haemoglobin levels of 62.5% COVID-19 positive cases in the present study were found below their normal levels which presumably and mainly is due to nutritional deficiencies highly and quite prevalent in Indian population. ...
Evaluating effects of allo-vedic preparation Raj Nirwan Bati on symptomatic cases of COVID-19 at a tertiary level health care facility in rural setting of northern India
Article
Full-text available
  • Oct 2021
Background: The present pandemic of COVID-19 has created a huge pressure on the current health system of the world as the burden is increasing exponentially day by day. Study evaluated the effect of the novel allo-vedic formulation named Raj Nirwan Bati (RNB) on the clinical symptoms, microbiological, bio-chemical, haematological and radiological profile of patients of COVID-19.Methods: Prospective single arm, non- randomized clinical trial was conducted which enrolled 40 reverse transcriptase-polymerase chain reaction (RT-PCR) confirmed patients of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). Each patient was given one dosage of RNB twice a day for 10 days. Patients were evaluated on the clinical symptoms, microbiological, bio-chemical, haematological and radiological profile of patients of COVID-19. Cochran’s Q tests was used to assess statistical significance.Results: The study revealed that 31 (77.5%) of the COVID-19 cases were having mild, 6 (15%) moderate and 3 (7.5%) having severe form of illness. The association between absence of clinical symptom (fever, cough, breathlessness, sore throat, fatigue and myalgia) and the day of evaluation (first, fifth and tenth day) after start of RNB intervention was found to be statistically significant (p<0.001, p<0.001, p=0.002, p<0.001, p<0.001 and p<0.001) respectively. Thirty (75.0%) of the cases on RNB intervention became negative for SARS-CoV-2 after day 5 on naso-pharyngeal and oro-pharyngeal RT-PCR testing (p<0.001). Statistically significant association was observed only for changes in proportion of cases with elevated lactate dehydrogenase (LDH) values and C-reactive protein (CRP) positive from day 1 to day 10 of RNB intervention (p<0.001).Conclusions: RNB may be considered a drug to fight against COVID-19.
View
ResearchGate has not been able to resolve any references for this publication.